Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Intelligent Bio Solutions...

    NASDAQ: INBS · Real-Time Price · USD
    1.55
    -0.14 (-8.28%)
    At close: Jun 27, 2025, 3:59 PM
    1.53
    -1.29%
    After-hours: Jun 27, 2025, 05:47 PM EDT

    Intelligent Bio Solutions Statistics

    Share Statistics

    Intelligent Bio Solutions has 6.91M shares outstanding. The number of shares has increased by 117.63% in one year.

    Shares Outstanding

    n/a
    		 6.91M

    Shares Change (YoY)

    n/a
    		 117.63%

    Shares Change (QoQ)

    n/a
    		 54.63%

    Owned by Institutions (%)

    n/a
    		 1.69%

    Shares Floating

    n/a
    		 6.82M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,680

    FTD / Avg. Volume

    n/a
    		 4.79%

    Short Selling Information

    The latest short interest is 528.47K, so 7.65% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 528.47K

    Short % of Shares Out

    n/a
    		 7.65%

    Short % of Float

    n/a
    		 7.75%

    Short Ratio (days to cover)

    n/a
    		 6.43

    Valuation Ratios

    The PE ratio is -0.57 and the forward PE ratio is 4.86. Intelligent Bio Solutions's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.57

    Forward PE

    n/a
    		 4.86

    PS Ratio

    n/a
    		 1.87

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 0.7

    P/FCF Ratio

    n/a
    		 -0.6

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Intelligent Bio Solutions.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 1.57

    Quick Ratio

    n/a
    		 1.42

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.1

    Debt / FCF

    n/a
    		 -0.09

    Interest Coverage

    n/a
    		 -61.52

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $62,240

    Profits Per Employee

    n/a
    		 $-203,140

    Employee Count

    n/a
    		 50

    Asset Turnover

    n/a
    		 0.23

    Inventory Turnover

    n/a
    		 2.17

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -9.63% in the last 52 weeks. The beta is 4.58, so Intelligent Bio Solutions's price volatility has been higher than the market average.

    Beta

    n/a
    		 4.58

    52-Week Price Change

    n/a
    		 -9.63%

    50-Day Moving Average

    n/a
    		 1.45

    200-Day Moving Average

    n/a
    		 1.63

    Relative Strength Index (RSI)

    n/a
    		 51.78

    Average Volume (20 Days)

    n/a
    		 118,500

    Income Statement

    In the last 12 months, Intelligent Bio Solutions had revenue of 3.11M and earned -10.16M in profits. Earnings per share was -6.38.

    Revenue

    n/a
    		 3.11M

    Gross Profit

    n/a
    		 1.43M

    Operating Income

    n/a
    		 -10.28M

    Net Income

    n/a
    		 -10.16M

    EBITDA

    n/a
    		 -8.81M

    EBIT

    n/a
    		 -10.02M

    Earnings Per Share (EPS)

    n/a
    		 -6.38
    Full Income Statement

    Balance Sheet

    The company has 6.3M in cash and 871.44K in debt, giving a net cash position of 5.43M.

    Cash & Cash Equivalents

    n/a
    		 6.3M

    Total Debt

    n/a
    		 871.44K

    Net Cash

    n/a
    		 5.43M

    Retained Earnings

    n/a
    		 -51.96M

    Total Assets

    n/a
    		 9.58M

    Working Capital

    n/a
    		 542.95K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.57M and capital expenditures -221.43K, giving a free cash flow of -9.79M.

    Operating Cash Flow

    n/a
    		 -9.57M

    Capital Expenditures

    n/a
    		 -221.43K

    Free Cash Flow

    n/a
    		 -9.79M

    FCF Per Share

    n/a
    		 -3.07
    Full Cash Flow Statement

    Margins

    Gross margin is 45.81%, with operating and profit margins of -330.46% and -326.4%.

    Gross Margin

    n/a
    		 45.81%

    Operating Margin

    n/a
    		 -330.46%

    Pretax Margin

    n/a
    		 -327.5%

    Profit Margin

    n/a
    		 -326.4%

    EBITDA Margin

    n/a
    		 -283.14%

    EBIT Margin

    n/a
    		 -330.43%

    FCF Margin

    n/a
    		 -314.68%

    Dividends & Yields

    INBS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for INBS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 29, 2024. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Jan 29, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 -10.52

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist